Daniel Alkon

Insider profile

Currently holds positions in TAO Synergies Inc and Neurotrope Inc

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Scientific Officer TAO Synergies Inc None -
President, Chief Scientific Officer Neurotrope Inc Sept. 23, 2016 -
Chief Scientific Officer Neurotrope Inc Aug. 1, 2013 - Sept. 23, 2016

Daniel Alkon's trades of TAO Synergies Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
271.92
Quantity 15,173 +26.2%
Value US$2,598,908
Transaction date
Purchase
Price
267.12
Quantity 44,006 +48.4%
Value US$2,323,201
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-12-20 2022-12-16 PlS Planned sale
15,173 +26.2%
271.92
US$2,598,908
15,173 +26.2% 271.92 US$2,598,908
2021-06-16 2021-06-14 B Purchase
44,006 +48.4%
267.12
US$2,323,201
44,006 +48.4% 267.12 US$2,323,201